Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients With Heart Failure
暂无分享,去创建一个
M. Borggrefe | J. Kautzner | F. Braunschweig | M. Cowie | G. Jondeau | I. Ford | Cheuk-Man Yu | D. V. van Veldhuisen | V. Conraads | R. Muñoz Aguilera | M. Lunati | B. Gerritse | D. V. Veldhuisen | R. Aguilera
[1] C. O’loughlin,et al. Clinical deterioration in established heart failure: What is the value of BNP and weight gain in aiding diagnosis? , 2005, European journal of heart failure.
[2] William T. Abraham,et al. Focused Update : ACCF / AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults , 2013 .
[3] D. Mozaffarian,et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[4] L. Stevenson,et al. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.
[5] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[6] Domenico Catanzariti,et al. Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: A case-control study , 2007, Journal of Interventional Cardiac Electrophysiology.
[7] D. Mozaffarian,et al. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[8] D. J. Veldhuisen,et al. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT‐HF) ☆ , 2008, European journal of heart failure.
[9] Christian Butter,et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. , 2007, European heart journal.
[10] William T. Abraham,et al. Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure , 2010, Circulation.
[11] Jeroen J. Bax,et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure , 2010, European journal of heart failure.
[12] M. Zile,et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. , 2008, Journal of the American College of Cardiology.
[13] P. Schauerte,et al. European InSync Sentry Observational Study Investigators. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure , 2007 .
[14] Finn Gustafsson,et al. 2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .
[15] R. Canby,et al. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). , 2011, Congestive heart failure.
[16] D. Zenker,et al. Intrathoracic impedance monitoring to detect chronic heart failure deterioration: Relationship to changes in NT‐proBNP , 2007, European journal of heart failure.
[17] W. Abraham,et al. Continuous Autonomic Assessment in Patients With Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device , 2004, Circulation.
[18] L. Tavazzi,et al. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. , 2011, European heart journal.
[19] J. Camm,et al. Successful treatment of heart failure with devices requires collaboration , 2008, European journal of heart failure.
[20] N Freemantle,et al. The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.
[21] A. V. Peterson,et al. On the regression analysis of multivariate failure time data , 1981 .
[22] L. Stevenson,et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.
[23] F. Oliva,et al. Monitoring Intrathoracic Impedance with an Implantable Defibrillator Reduces Hospitalizations in Patients with Heart Failure , 2009, Pacing and clinical electrophysiology : PACE.
[24] Jeroen J. Bax,et al. Intrathoracic impedance monitoring to predict decompensated heart failure. , 2007, The American journal of cardiology.
[25] W. Tang,et al. Measuring impedance in congestive heart failure: current options and clinical applications. , 2009, American heart journal.
[26] Sana M. Al-Khatib,et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. , 2010, Journal of the American College of Cardiology.
[27] C. O'connor,et al. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. , 2007, JAMA.
[28] Milton Packer,et al. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. , 2006, Journal of the American College of Cardiology.
[29] C. Lau,et al. Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization , 2005, Circulation.
[30] D. Hettrick,et al. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. , 2009, Journal of cardiac failure.
[31] K. Dickstein,et al. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008 , 2009, European journal of heart failure.
[32] J Taylor,et al. Focused update of the ESC Guidelines on device therapy in heart failure. , 2010, European heart journal.